AstraZeneca Joins Pharma Investment Push in U.S. Amid Tariff Threat

The U.K.-based drug maker plans to invest $50 billion in the United States as the industry seeks to appease President Trump.

Jul 23, 2025 - 00:00
 0  0
AstraZeneca Joins Pharma Investment Push in U.S. Amid Tariff Threat
The U.K.-based drug maker plans to invest $50 billion in the United States as the industry seeks to appease President Trump.